Association of Mean Pericoronary Adipose Tissue Attenuation with Different Demographic Factors in a Subgroup of Patients Without Coronary Artery Disease Stratified by Sex, Body Mass Index, and Age.
Gang Wang,Mengyuan Jing,Huaze Xi,Feng Lei,Wei Ren,Junlin Zhou
DOI: https://doi.org/10.21037/qims-23-951
2024-01-01
Quantitative Imaging in Medicine and Surgery
Abstract:Background: In patients without coronary artery disease (CAD), few studies have evaluated the association between mean pericoronary adipose tissue attenuation (PCATMA) and patient -based demographic factors, for example, age or sex. Therefore, the purpose of this study is to investigate the association between PCATMA and various demographic factors in patients without CAD. Methods: In this case -control study, the 806 patients who underwent coronary computed tomography angiography and were not diagnosed with CAD between July 2020 and July 2022 were retrospectively enrolled. Their PCATMA values of the proximal right coronary artery were measured automatically. Patients without CAD were stratified according to sex, body mass index (BMI), and age, and the relationship between PCATMA and different clinical characteristics was explored using Fisher's exact test or Chi -squared test and independent t -tests or Wilcoxon Mann -Whitney Utests. Results: Compared to non-smoking women [-88.00 (-95.00, -81.00) HU], women who smoked [-84.00 (-94.00, -78.00) HU, P=0.037] had higher PCATMA values and a positive correlation with PCATMA (rs=0.101, P=0.036). Compared to non -hypertensive patients with BMI 224.91 kg/m2 [-87.00 (-95.00, -81.00) HU], hypertensive patients with BMI 224.91 kg/m2 [-84.00 (-92.00, -78.00) HU, P=0.004] had higher PCATMA values, and a positive correlation with PCATMA (rs=0.144, P=0.004). In a subgroup of patients without CAD stratified by sex, BMI, and age, PCATMA values were all higher in patients with dyslipidemia (women, men, BMI 224.91 kg/m2, BMI <24.91 kg/m2, age 255 years, and age <55 years: -82.00, -82.00, -81.50, -82.00, - 81.00 and -83.50 HU, respectively) than in those without dyslipidemia (-89.00, -89.00, -89.00, -90.00, - 90.00 and -88.00 HU, respectively; all P<0.001) and showed a positive relationship (rs=0.328, 0.339, 0.342, 0.326, 0.367, and 0.298, respectively; all P<0.001). Conclusions: Higher PCATMA attenuation values were observed in patients with dyslipidemia, smoking women, and hypertensive patients with BMI 224.91 kg/m2, suggesting that PCATMA values can be used to detect patients at high risk for future events with CAD even if they do not currently have atherosclerosis.